Sunday, November 18, 2018

Aurobindo Pharma to launch oncology, respiratory products in US by 2021

The company is also planning to launch first set of biosimilars and vaccines in growth markets during this time, Aurobindo Pharma said in an investor presentation

from Latest News https://ift.tt/2DKg84V
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

Related Posts:

0 comments: